AAAAAA
Results: 1-25/93
Authors:
NAGLER A
BISHARA A
BRAUTBAR C
BARAK V
Citation: A. Nagler et al., DYSREGULATION OF INFLAMMATORY CYTOKINES IN UNRELATED BONE-MARROW TRANSPLANTATION, Cytokines cellular & molecular therapy, 4(3), 1998, pp. 161-167
Authors:
BARAK V
CONDIOTTI R
ZAKAI YB
NAGLER A
Citation: V. Barak et al., CYTOKINE LEVELS IN EX-VIVO EXPANDED CORD BLOOD-DERIVED NATURAL-KILLER(NK) CELLS, European cytokine network, 9(3), 1998, pp. 33-33
Authors:
BARAK V
POLLIACK A
NISMAN B
Citation: V. Barak et al., SOLUBLE IL-2 RECEPTOR AND BETA-2-MICROGLOBULIN LEVELS CORRELATE WITH DISEASE-ACTIVITY AND RESPONSE TO THERAPY IN LYMPHOMA AND CHRONIC LYMPHOCYTE LEUKEMIA, European cytokine network, 9(3), 1998, pp. 34-34
Authors:
BARAK V
SCHWARTZ A
KALICKMAN I
NISMAN B
GURMAN G
SHOENFELD Y
Citation: V. Barak et al., CYTOKINES AND HYPOPHOSPHATEMIA AS DIAGNOSTIC-TOOLS IN SEPSIS, European cytokine network, 9(3), 1998, pp. 35-35
Authors:
AMITAL H
LEVI Y
BLANK M
BARAK V
LANGEVITZ P
AFEK A
NICOLETTI F
KUPOLOVIC J
GILBURD B
MERONI PL
SHOENFELD Y
Citation: H. Amital et al., IMMUNOMODULATION OF MURINE EXPERIMENTAL SLE-LIKE DISEASE BY INTERFERON-GAMMA, European cytokine network, 9(3), 1998, pp. 396-396
Authors:
BARAK V
NISMAN B
POLLIACK A
VANNIER E
DINARELLO CA
Citation: V. Barak et al., CORRELATION OF SERUM LEVELS OF INTERLEUKIN-1 FAMILY MEMBERS WITH DISEASE-ACTIVITY AND RESPONSE TO TREATMENT IN HAIRY-CELL LEUKEMIA, European cytokine network, 9(1), 1998, pp. 33-39
Authors:
AMITAL H
LEVI Y
BLANK M
BARAK V
LANGEVIRZ P
AFEK A
NICOLETTI F
KOPOLOVIC J
GILBURD B
MERONI PL
SHOENFELD K
SHOENFELD Y
Citation: H. Amital et al., IMMUNOMODULATION OF MURINE EXPERIMENTAL SLE-LIKE DISEASE BY INTERFERON-GAMMA, Lupus, 7(7), 1998, pp. 445-454
Authors:
NISMAN B
LAFAIR J
LYASS O
DRANITZKIELHALEL M
BARAK V
Citation: B. Nisman et al., SERUM LEVELS OF CEA, SCC, TPS AND CYFRA-21-1 IN HEMODIALYSIS-PATIENTS, Journal of tumor marker oncology, 13(2), 1998, pp. 87-93
Authors:
NISMAN B
LAFAIR J
LYASS O
DRANITZKIELHALEL M
BARAK V
Citation: B. Nisman et al., SERUM LEVELS OF CEA, SCC, TPS AND CYFRA-21-1 IN HEMODIALYSIS-PATIENTS, Journal of tumor marker oncology, 13(1), 1998, pp. 33-39
Authors:
NISMAN B
BARAK V
HECHING N
KRAMER M
REINUS C
LAFAIR J
Citation: B. Nisman et al., CYTOKERATIN MARKERS IN MALIGNANT PLEURAL MESOTHELIOMA, Cancer detection and prevention, 22(5), 1998, pp. 416-421
Authors:
LEWIN A
BENJAMIN I
NADJARI YN
REUBINOFF B
SAFRAN A
USHAKOV F
SCHENKER J
BARAK V
Citation: A. Lewin et al., THE PREDICTIVE VALUE OF FOLLICULAR DOPPLER FLOW RESISTANCE INDEX AND SERUM AND FOLLICULAR-FLUID CONCENTRATIONS OF IGF-I AND VEGF FOR THE OUTCOME OF IVF, Human reproduction (Oxford. Print), 13, 1998, pp. 142-142
Authors:
BLANK M
GEORGE J
BARAK V
TINCANI A
KOIKE T
SHOENFELD Y
Citation: M. Blank et al., ORAL TOLERANCE TO LOW-DOSE BETA(2)-GLYCOPROTEIN - I - IMMUNOMODULATION OF EXPERIMENTAL ANTIPHOSPHOLIPID SYNDROME, The Journal of immunology (1950), 161(10), 1998, pp. 5303-5312
Authors:
BISHARA A
MALKA R
BRAUTBAR C
BARAK V
COHEN I
KEDAR E
Citation: A. Bishara et al., CYTOKINE PRODUCTION IN HUMAN MIXED LEUKOCYTE REACTIONS PERFORMED IN SERUM-FREE MEDIA, Journal of immunological methods, 215(1-2), 1998, pp. 187-190
Authors:
NISMAN B
LAFAIR J
HECHING N
LYASS O
BARAS M
PERETZ T
BARAK V
Citation: B. Nisman et al., EVALUATION OF TISSUE POLYPEPTIDE SPECIFIC ANTIGEN, CYFRA-21-1, AND CARCINOEMBRYONIC ANTIGEN IN NONSMALL CELL LUNG-CARCINOMA - DOES THE COMBINED USE OF CYTOKERATIN MARKERS GIVE ANY ADDITIONAL INFORMATION, Cancer, 82(10), 1998, pp. 1850-1859
Authors:
BLANK M
GEORGE J
FISHMAN P
LEVY Y
TODER V
SAVION S
BARAK V
KOIKE T
SHOENFELD Y
Citation: M. Blank et al., CIPROFLOXACIN IMMUNOMODULATION OF EXPERIMENTAL ANTIPHOSPHOLIPID SYNDROME-ASSOCIATED WITH ELEVATION OF INTERLEUKIN-3 AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR EXPRESSION, Arthritis and rheumatism, 41(2), 1998, pp. 224-232
Authors:
DEUTSCH E
KAUFMAN M
NISMAN B
BARAK V
Citation: E. Deutsch et al., CYTOKINE EVALUATION IN THROAT INFECTIONS, The Annals of otology, rhinology & laryngology, 107(8), 1998, pp. 713-716
Authors:
BARAK V
SCHWARTZ A
KALICKMAN I
NISMAN B
GURMAN G
SHOENFELD Y
Citation: V. Barak et al., PREVALENCE OF HYPOPHOSPHATEMIA IN SEPSIS AND INFECTION - THE ROLE OF CYTOKINES, The American journal of medicine, 104(1), 1998, pp. 40-47
Authors:
TOREN A
BARAK V
NOVICK D
NAGLER A
Citation: A. Toren et al., SOLUBLE INTERFERON-GAMMA RECEPTOR AND INTERFERON-GAMMA IN PATIENTS UNDERGOING ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR HEMATOLOGICAL MALIGNANCIES, Cytokines cellular & molecular therapy, 3(3), 1997, pp. 153-158
Authors:
MERIMSKY O
HAREUVENI M
BARAK V
SPERBER F
ESHKOL Z
CHAITCHIK S
Citation: O. Merimsky et al., ELEVATED BREAST-CANCER SERUM MARKERS IN OTHERWISE HEALTHY WOMEN, Oncology Reports, 4(4), 1997, pp. 829-832
Authors:
LEVY Y
GEORGE J
BARAK V
SHOENFELD Y
Citation: Y. Levy et al., EARLY DETECTION OF RECURRENT MONO-METASTASES OF BREAST-CANCER TO ENDOCRINE TISSUES BY FOLLOWING CEA LEVELS, Oncology Reports, 4(3), 1997, pp. 623-624
Authors:
SHAPIRA L
SOSKOLNE A
HALABI A
BARAK V
STABHOLZ A
Citation: L. Shapira et al., INDUCTION OF TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-1-BETA IN SUBCUTANEOUSLY IMPLANTED CHAMBER BY LIPOPOLYSACCHARIDE, Journal of endotoxin research, 4(5), 1997, pp. 325-329
Authors:
PERETZ T
KAPLANDENOUR A
BAIDER L
HUBERT A
STEPHANOS S
BARAK V
Citation: T. Peretz et al., COMBINATION OF INTERFERON AND TAMOXIFEN FOR PATIENTS WITH ADVANCED BREAST-CANCER AND NEGATIVE ESTROGEN-RECEPTORS, Breast, 6(4), 1997, pp. 190-193
Authors:
BARAK V
NISMAN B
ROISMAN I
HUBERT A
FARBSTEIN H
BAIDER L
KAPLAN A
HALPERIN T
STEPHANOS S
PERETZ T
Citation: V. Barak et al., TPS IN ASSESSING RESPONSE TO THERAPY AND PROGNOSIS OF BREAST-CANCER PATIENTS TREATED WITH INTERFERONS, Journal of tumor marker oncology, 12(4), 1997, pp. 17-25
Authors:
TOREN A
BARAK V
NOVICK D
NAGLE A
Citation: A. Toren et al., SOLUBLE INTERFERON-GAMMA RECEPTOR (SIFN-GAMMA-R) AND INTERFERON-GAMMA(IFN-GAMMA) LEVELS IN HEMATOLOGY PATIENTS UNDERGOING BONE-MARROW TRANSPLANTATION (BMT), Experimental hematology, 25(8), 1997, pp. 128-128
Authors:
NAGLER A
BARAK V
BISHARA A
Citation: A. Nagler et al., INFLAMMATORY CYTOKINES DYSREGULATION IN UNRELATED BONE-MARROW TRANSPLANTATION (BMT), Experimental hematology, 25(8), 1997, pp. 129-129